Navigation Links
Elsevier's PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
Date:10/14/2008

tant dimension to our coverage," said MacLaughlin. "This information will benefit companies operating globally because it provides critical access to another major regulatory body's points of view, precedents and data, including drugs approved only in Europe, and the availability of this information, combined with the FDA documents and other PharmaPendium data sources, will lead to a deeper understanding of the full scope of projected risks early in the drug development process and consequently reduce drug development costs and avoid regulatory cycling."

The EMEA Documents database is included as part of PharmaPendium licensing agreements at no additional fee and the content is automatically available to all users. More information about the European Medicines Agency and EMEA approval documents can be found at http://www.info.pharmapendium.com/emea.

About PharmaPendium(TM)

PharmaPendium (http://www.info.pharmapendium.com), The Essential Resource for Preclinical Safety and Risk Assessment, is a unique online resource that provides access via a single point to searchable and trusted drug information. It covers over 3100 approved drugs, with integrated preclinical, clinical and post-marketing safety data.

PharmaPendium is designed to meet the needs of preclinical safety assessment teams, toxicologists, pharmacokineticists, safety pharmacologists, regulatory affairs staff, pharmacoepidemiologists, clinical researchers and information specialists. It enables text-search of FDA Approval Packages and European Medicines Agency (EMEA) European Public Assessment Reports (EPAR) Approval Documents as well as other data sources. Adverse events and toxicity data are carefully extracted from preclinical and clinical studies from all of these sources. Elsevier offers a broad spectrum of solutions to make processes in drug disco
'/>"/>

SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
3. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
4. Kline Study: Better Brushing Habits Boost European Oral Care Sales
5. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
6. European Centre for Modern Drug Discovery Established in Hamburg
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
9. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
10. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
11. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
(Date:12/19/2014)... 18, 2014 BioPlus Specialty ... specialty pharmacies, has an expanded team of Regional ... consultants for prescriber offices in their regions, with ... “We have a variety of Regional Pharmaceutical Care ... specializing in hepatitis C help prescribers understand all ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... MILLBROOK, N.Y. , Dec. 18, 2014 Egenix, ... has been elected Chairman of the Board, to succeed ... President and CEO, but will continue as a member of ... that he has added to the company over almost twenty ... The Board of Directors has established a Search ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... Calif., July 7, 2011 InterMune (NASDAQ: ... in ASCEND, a new Phase 3 study of pirfenidone ...  ASCEND is a multinational, randomized, double-blind, placebo controlled Phase ... of Esbriet® (pirfenidone) in IPF patients with mild to ...
... America, Inc . ( www.cordblood-america.com ) (OTC Bulletin Board: ... preservation company focused on bringing the life saving potential ... today that CorCell, its domestic brand for cord blood stem ... Rewards Program in the U.S. for the collection of a ...
... a.m. EDT, the space shuttle Atlantis will streak skyward from ... mission. While the STS-135 flight marks the end of the ... new era of research into infectious diseases, thanks to space ... III, along with their colleagues at Arizona State University,s Biodesign ...
Cached Biology Technology:InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 2InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 3InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 4InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 5CorCell, a Cord Blood America Company, Launches Referral Rewards Program 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 4
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Munich, Germany March 2, 2009 >> Genomatix Software, ... of Next Generation Sequencing (NGS) data, announced today that ... Genomatix Mining Station and a Genomatix Genome Analyzer at ... deliver the only complete and integrated analysis solution for ...
... An international team of scientists, led by Monash University ... kills elderly hospital patients worldwide - a discovery that ... systems billions of dollars each year. The research ... , unravelled ways to genetically modify the bacterium ...
... a picky preschooler who,s avoiding their vegetables? A new Cornell ... like X-Ray Vision Carrots and Tomato Bursts left preschoolers ... carrots called "X-ray Vision Carrots" ate nearly twice as much ... simply labeled as "carrots." The Robert Wood Johnson-funded study also ...
Cached Biology News:Boehringer Ingelheim uses Genomatix' Next Generation Sequencing data analysis systems 2Monash scientists debug superbug 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
... histochemically detect specific senescence ... in cultured cells and ... marker is only present ... found in presenescent/quiescent/immortal cells. ...
TAR DNA binding protein...
... BL21 Star strains are ... for improved protein yield ... systems (Figure 1). Because ... synthesizes mRNA more rapidly ...
Biology Products: